Skip to main content
Log in

Discovering Peptide Inhibitors of Human Squalene Synthase Through Screening the Phage-Displayed Cyclic Peptide c7c Library

  • Published:
Applied Biochemistry and Biotechnology Aims and scope Submit manuscript

Abstract

Many drugs for the treatment of hypercholesterolemia are targeting the enzymes involved in human cholesterol biosynthesis pathway. Squalene synthase, the rate-limiting enzyme located at the downstream of cholesterol synthesis pathway, has become a better candidate to develop next-generation hypocholesterolemia drugs. In the present study, we cloned and expressed the recombinant human squalene synthase (hSQS) as the lure to isolate potential peptide inhibitors from screening the conformation-constrained phage-displayed cyclic peptide c7c library. Their binding capabilities were further estimated by ELISA. Their pharmaceutical potentials were then analyzed through molecular modeling and the ADMET property evaluations. Four ennea-peptides and nine tetra-peptides were finally synthesized to evaluate their inhibitory potentials toward hSQS. The results indicate that the ennea-peptide CLSPHSMFC, tetra-peptides SMFC, CKTE, and WHQW can effectively inhibit hSQS activities (IC50 values equal to 64, 76, 87, and 90 μM, respectively). These peptides may have potentials to develop future cholesterol-lowering therapeutics. The ligand-protein interaction analysis also reveals that the inner hydrophobic pocket could be a more critical site of hSQS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

ELISA:

Enzyme-linked immunosorbent assay

hHMGR:

Human 3-hydroxy-3-methylglutaryl-coenzyme A reductase

hSQS:

Human squalene synthase

IPTG:

Isopropyl β-d-1-thiogalactopyranoside

LDL-R:

Low-density lipoprotein receptor

SDS-PAGE:

Sodium dodecyl sulfate-polyacrylamide gel electrophoresis

References

  1. Steinberg, D., & Gotto, A. M. (1999). Preventing coronary artery disease by lowering cholesterol levels: fifty years from bench to bedside. Journal of the American Medical Association, 282, 2043–2050.

    Article  CAS  Google Scholar 

  2. Goldstein, J. L., & Brown, M. S. (1990). Regulation of the mevalonate pathway. Nature, 343, 425–430.

    Article  CAS  Google Scholar 

  3. Brown, A. S., Bakker-Arkema, R. G., Yellen, L., Henley, R. W., Guthrie, R., Campbell, C. F., Koren, M., Woo, W., McLain, R., & Black, D. M. (1998). Treating patients with documented atherosclerosis to National Cholesterol Education Program-recommended low-density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatin. Journal of the American College of Cardiology, 32, 665–672.

    Article  CAS  Google Scholar 

  4. Hsu, I., Spinler, S. A., & Johnson, N. E. (1995). Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia. The Annals of Pharmacotherapy, 29, 743–759.

    CAS  Google Scholar 

  5. Satoh, K., Yamato, A., Nakai, T., Hoshi, K., & Ichihara, K. (1995). Effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on mitochondrial respiration in ischaemic dog hearts. British Journal of Pharmacology, 116, 1894–1898.

    Article  CAS  Google Scholar 

  6. Ichihara, K., Satoh, K., & Abiko, Y. (1993). Influences of pravastatin and simvastatin, HMG-CoA reductase inhibitors, on myocardial stunning in dogs. Journal of Cardiovascular Pharmacology, 22, 852–856.

    Article  CAS  Google Scholar 

  7. Liao, J. K. (2011). Squalene synthase inhibitor lapaquistat acetate: could anything be better than statins? Circulation, 123, 1925–1928.

    Article  Google Scholar 

  8. Pandit, J., Danley, D. E., Schulte, G. K., Mazzalupo, S., Pauly, T. A., Hayward, C. M., Hamanaka, E. S., Thompson, J. F., & Harwood, H. J. (2000). Crystal structure of human squalene synthase. A key enzyme in cholesterol biosynthesis. Journal of Biological Chemistry, 275, 30610–30617.

    Article  CAS  Google Scholar 

  9. Stein, E. A., Bays, H., O’Brien, D., Pedicano, J., Piper, E., & Spezzi, A. (2011). Lapaquistat acetate: development of a squalene synthase inhibitor for the treatment of hypercholesterolemia. Circulation, 123, 1974–1985.

    Article  CAS  Google Scholar 

  10. Singh, B. P., Vij, S., & Hati, S. (2014). Functional significance of bioactive peptides derived from soybean. Peptides, 54, 171–179.

    Article  CAS  Google Scholar 

  11. Cho, S. J., Juillerat, M. A., & Lee, C. H. (2007). Cholesterol lowering mechanism of soybean protein hydrolysate. Journal of Agricultural and Food Chemistry, 55, 10599–10604.

    Article  CAS  Google Scholar 

  12. Smith, G. P. (1985). Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science, 228, 1315–1317.

    Article  CAS  Google Scholar 

  13. Shiuan, D., Lin, H. K., Chen, Y. H., Chang, D. K., Huang, K. J., & Farh, L. (2015). Exploration of peptide inhibitors of human squalene synthase through molecular modeling and phage display technique. Applied Biochemistry and Biotechnology, 178, 312–323.

    Article  Google Scholar 

  14. O’Neil, K. T., Hoess, R. H., Jackson, S. A., Ramachandran, N. S., Mousa, S. A., & DeGrado, W. F. (1992). Identification of novel peptide antagonists for GPIIb/ IIIa from a conformationally constrained phage peptide library. Proteins, 14, 509–515.

    Article  Google Scholar 

  15. McLafferty, M. A., Kent, R. B., Ladner, R. C., & Markland, W. (1993). M13 bacteriophage displaying disulfide-constrained microproteins. Gene, 128, 29–36.

    Article  CAS  Google Scholar 

  16. Liu, C.I., Liu, Y., Song, G.Y., Yin, F., Hensler, M.E., Jeng, W.Y., Nizet, V., Wang, A.H.J., & Oldfield, E. A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence. Science, 319, 1391–1394.

  17. Lin, S. H., Chang, D. K., Chou, M. J., & Shiuan, D. (2015). Peptide inhibitors of human HMG-CoA reductase as potential hypocholesterolemic agents. Biochemistry and Biophysical Research Communications, 456, 104–109.

    Article  CAS  Google Scholar 

  18. Yang, W. J., Lai, J. F., Peng, K. C., Chiang, H. J., Weng, C. N., & Shiuan, D. (2005). Epitope mapping of Mycoplasma hyopneumoniae using phage displayed peptide libraries and the immune responses of the selected phagotopes. Journal of Immunological Methods, 304, 15–29.

    Article  CAS  Google Scholar 

  19. Lin, K. C., Chen, C. Y., Huang, K. J., Chang, C. W., Lin, S. P., Chang, D. K., Lin, M. R., & Shiuan, D. (2012). A dodecapeptide (YQVTQSKVMSHR) exhibits antibacterial effect and induces cell aggregation in Escherichia coli. Applied Microbiology and Biotechnology, 94, 755–762.

    Article  CAS  Google Scholar 

  20. Venkatachalam, C. M., Jiang, X., Oldfield, T., & Waldman, M. (2003). LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites. Journal of Molecular Graphics & Modeling, 21, 289–307.

    Article  CAS  Google Scholar 

  21. Tansey, T. R., & Shechter, I. (2000). Structure and regulation of mammalian squalene synthase. Biochimica et Biophysics Acta, 1529, 49–62.

    Article  CAS  Google Scholar 

  22. Stevens, D. (2003). Methods for determining squalene synthase activity. US Patent. 2003; US 20030157583 A1.

  23. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 72, 248–254.

    Article  CAS  Google Scholar 

  24. van Meerloo, J., Kaspers, G. J., & Cloos, J. (2001). Cell sensitivity assays: the MTT assay. Methods in Molecular Biology, 731, 237–245.

    Article  Google Scholar 

  25. Fosgerau, K., & Hoffmann, T. (2015). Peptide therapeutics: current status and future directions. Drug Discovery Today, 20, 122–128.

    Article  CAS  Google Scholar 

  26. Torchilin, V. P., & Lukyanov, A. N. (2003). Peptide and protein drug delivery to and into tumors: challenges and solutions. Drug Discovery Today, 8, 259–266.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This work was partially supported by grants from the Ministry of Science and Technology, Taiwan, ROC (NSC97-2311-B259-04-MY3 to D. Shiuan, MOST 103-2113-M-259-019 to D. F. Tai and NSC99-2113-M-001-024-MY3 to D. K. Chang.).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David Shiuan.

Electronic Supplementary Material

Below is the link to the electronic supplementary material.

ESM 1

(DOCX 846 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shiuan, D., Chen, YH., Lin, HK. et al. Discovering Peptide Inhibitors of Human Squalene Synthase Through Screening the Phage-Displayed Cyclic Peptide c7c Library. Appl Biochem Biotechnol 179, 597–609 (2016). https://doi.org/10.1007/s12010-016-2016-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12010-016-2016-9

Keywords

Navigation